Cinnamic acid, 3-phenylpropyl ester
Common Name: |
Cinnamic acid, 3-phenylpropyl ester |
IUPAC Name: |
3-phenylpropyl (Z)-3-phenylprop-2-enoate |
Molecular Formula: |
C18H18O2 |
SMILES: |
C1=CC=C(C=C1)CCCOC(=O)C=CC2=CC=CC=C2 |
Inchi: |
1S/C18H18O2/c19-18(14-13-17-10-5-2-6-11-17)20-15-7-12-16-8-3-1-4-9-16/h1-6,8-11,13-14H,7,12,15H2/b14-13- |
Inchi Key: |
LYRAHIUDQRJGGZ-YPKPFQOOSA-N |
Cas No: |
122-68-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
266.33 |
Mass (g/mol) |
266.131 |
Molar Refractivity |
81.53 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
7 |
Rings |
2 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
20 |
Aromatic Heavy Atoms |
12 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
190.00 @ 0.20 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.17 |
LogP |
3.876 |
iLOGP |
3.41 |
XLOGP3 |
4.94 |
WLOGP |
3.77 |
MLOGP |
4.05 |
ESOL Log S |
-4.59 |
ESOL Solubility (mg/ml) |
0.007 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.23 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-5.91 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.42 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.852 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.645 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |